Cargando…

Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients

BACKGROUND: Though von Willebrand disease (VWD) is a common coagulation disorder, due to the complexity of the molecular analysis of von Willebrand factor gene (VWF), not many reports are available from this country. Large size of the gene, heterogeneous nature of mutations and presence of a highly...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasatkar, Priyanka, Shetty, Shrimati, Ghosh, Kanjaksha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967998/
https://www.ncbi.nlm.nih.gov/pubmed/24675615
http://dx.doi.org/10.1371/journal.pone.0092575
_version_ 1782309093324619776
author Kasatkar, Priyanka
Shetty, Shrimati
Ghosh, Kanjaksha
author_facet Kasatkar, Priyanka
Shetty, Shrimati
Ghosh, Kanjaksha
author_sort Kasatkar, Priyanka
collection PubMed
description BACKGROUND: Though von Willebrand disease (VWD) is a common coagulation disorder, due to the complexity of the molecular analysis of von Willebrand factor gene (VWF), not many reports are available from this country. Large size of the gene, heterogeneous nature of mutations and presence of a highly homologous pseudogene region are the major impediments in the genetic diagnosis of VWD. The study is aimed at unravelling the molecular pathology in a large series of VWD patients from India using an effective strategy. METHOD: We evaluated 85 unrelated Indian type 3 VWD families to identify the molecular defects using a combination of techniques i.e. PCR-RFLP, direct DNA sequencing and multiple ligation probe amplification (MLPA). RESULTS: Mutations could be characterized in 77 unrelated index cases (ICs). 59 different mutations i.e. nonsense 20 (33.9%), missense 13 (22%), splice site 4 (6.8%), gene conversions 6 (10.2%), insertions 2 (3.4%), duplication 1 (1.7%), small deletions 10 (17%) and large deletions 3 (5.1%) were identified, of which 34 were novel. Two common mutations i.e. p.R1779* and p.L970del were identified in our population with founder effect. Development of alloantibodies to VWF was seen in two patients, one with nonsense mutation (p.R2434*) and the other had a large deletion spanning exons 16–52. CONCLUSION: The molecular pathology of a large cohort of Indian VWD patients could be identified using a combination of techniques. A wide heterogeneity was observed in the nature of mutations in Indian VWD patients.
format Online
Article
Text
id pubmed-3967998
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39679982014-04-01 Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients Kasatkar, Priyanka Shetty, Shrimati Ghosh, Kanjaksha PLoS One Research Article BACKGROUND: Though von Willebrand disease (VWD) is a common coagulation disorder, due to the complexity of the molecular analysis of von Willebrand factor gene (VWF), not many reports are available from this country. Large size of the gene, heterogeneous nature of mutations and presence of a highly homologous pseudogene region are the major impediments in the genetic diagnosis of VWD. The study is aimed at unravelling the molecular pathology in a large series of VWD patients from India using an effective strategy. METHOD: We evaluated 85 unrelated Indian type 3 VWD families to identify the molecular defects using a combination of techniques i.e. PCR-RFLP, direct DNA sequencing and multiple ligation probe amplification (MLPA). RESULTS: Mutations could be characterized in 77 unrelated index cases (ICs). 59 different mutations i.e. nonsense 20 (33.9%), missense 13 (22%), splice site 4 (6.8%), gene conversions 6 (10.2%), insertions 2 (3.4%), duplication 1 (1.7%), small deletions 10 (17%) and large deletions 3 (5.1%) were identified, of which 34 were novel. Two common mutations i.e. p.R1779* and p.L970del were identified in our population with founder effect. Development of alloantibodies to VWF was seen in two patients, one with nonsense mutation (p.R2434*) and the other had a large deletion spanning exons 16–52. CONCLUSION: The molecular pathology of a large cohort of Indian VWD patients could be identified using a combination of techniques. A wide heterogeneity was observed in the nature of mutations in Indian VWD patients. Public Library of Science 2014-03-27 /pmc/articles/PMC3967998/ /pubmed/24675615 http://dx.doi.org/10.1371/journal.pone.0092575 Text en © 2014 Kasatkar et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kasatkar, Priyanka
Shetty, Shrimati
Ghosh, Kanjaksha
Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
title Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
title_full Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
title_fullStr Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
title_full_unstemmed Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
title_short Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
title_sort genetic heterogeneity in a large cohort of indian type 3 von willebrand disease patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967998/
https://www.ncbi.nlm.nih.gov/pubmed/24675615
http://dx.doi.org/10.1371/journal.pone.0092575
work_keys_str_mv AT kasatkarpriyanka geneticheterogeneityinalargecohortofindiantype3vonwillebranddiseasepatients
AT shettyshrimati geneticheterogeneityinalargecohortofindiantype3vonwillebranddiseasepatients
AT ghoshkanjaksha geneticheterogeneityinalargecohortofindiantype3vonwillebranddiseasepatients